Skip to main content
. Author manuscript; available in PMC: 2014 May 29.
Published in final edited form as: Leuk Res. 2013 Jun 20;37(9):1116–1119. doi: 10.1016/j.leukres.2013.05.016

Table 3.

Characteristics of 31 patients with leukemic follicular lymphoma from the literature

Characteristic Number Percentage
Age >60 years 15/31 48.4%
Male sex 22/31 71.0%
Region
  Europe 15/31 48.4%
  America 8/31 25.8%
  Asia 8/31 25.8%
Concurrent tumors 21/26 80.8%
Blood only 5/26 19.2%
B symptoms 6/15 40.0%
FLIPI
  Low (0–2 points) 8/17 47.1%
  High (3–5 points) 9/17 52.9%
WBC count >100/uL 8/27 29.6%
CD10 expression 27/29 93.1%
CD20 expression 31/31 100%
BCL2/IgH gene rearrangement* 19/22 86.4%
Therapy
  R-chemotherapy 17/24 70.8%
  Chemotherapy 6/24 25.0%
  None 1/24 4.2
Outcome
  Alive 22/26 84.6%
  Dead 4/26 15.4%

FLIPI: follicular lymphoma international prognostic index; WBC: white blood cell; IgH: immuhoglobulin heavy chain

*

By FISH or PCR